Dechra Pharmaceuticals Plc stock soared after the veterinary drugmaker confirmed it is in discussions with EQT AB about a possible all-cash takeover in what could be one of the largest U.K. take-private deals this year.
To read the entire story, you must be logged in.
Please log in now or register with us.
